Diagnoses treated, medications tried and failed, and patient's response to itch or burning sensations following nemolizumab
Published: 4 March 2025| Version 5 | DOI: 10.17632/whnfd5n4ys.5
Contributors:
Emi Murase, Ajay Dulai, Sammer Marzouk, Peter Lio, Raja Sivamani, Jenny MuraseDescription
Summary of patient demographics, diagnoses associated with pruritus, duration of skin disease, topical medication, phototherapy treatment, oral antihistamine, oral neuropathic agents, oral antibiotics, systemic anti-inflammatory therapy, number and dosage of nemolizumab received, clinical itch or burning response reported as both percentage improvement and NRS (Peak Pruritus or Burning Numerical Rating Sale), and adverse reactions are reported.
Files
Categories
Dermatology